Daxas
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Daxas, covering 2013-09-19 to 2026-02-25. Get the full timeline:
Most recent: EMA Authorised: Daxas (roflumilast) — AstraZeneca AB
5 regulatory and trial events tracked for Daxas, covering 2013-09-19 to 2026-02-25. Get the full timeline:
Most recent: EMA Authorised: Daxas (roflumilast) — AstraZeneca AB